Iron Dome Acquisition I Corp. Files Registration Statement for a $200 Million Proposed Initial Public Offering

NEW YORK, NY / ACCESS Newswire / February 2, 2026 / Iron Dome Acquisition I Corp. ("IDAC"), a blank check company ...

D. Boral Capital Acted as Sole Bookrunner to GigCapital9 Corp. (Nasdaq: GIX) in Connection with its $253,000,000 Initial Public Offering

NEW YORK, NY / ACCESS Newswire / January 29, 2026 / On January 28, 2026, GigCapital9 Corp. closed its Initial Public ...

Bankers Tee Up Busiest IPO Week Since 2021 After Choppy Start

Eight companies are targeting a collective $3.9 billion in what’s set to be the busiest week for US initial public offerings ...

D. Boral Capital Acted as Sole Bookrunner to K2 Capital Acquisition Corporation (Nasdaq: KTWOU) in Connection with its $138,000,000 Initial Public Offering

On Jan. 30, 2026, K2 Capital Acquisition Corporation (NASDAQ:KTWOU) (the "Company") announced the closing of its upsized ...

India's Fractal Analytics cuts IPO size by over 40% to $314 million

Feb 3 (Reuters) - Indian enterprise artificial intelligence firm Fractal Analytics has cut the size of its initial public ...

Austin fitness company tied to Mark Wahlberg settles shareholder lawsuit

F45 Training misled investors about growth prospects ahead of its 2021 initial public offering, the suit said. A settlement ...

Research finds 'cheap stock' options common before IPOs, averaging fivefold gains

Before the opening bell ever rings on a company's initial public offerings, some of the executives may already be sitting on ...

Hong Kong IPO Market Records Second-Strongest January on Record

Hong Kong's initial public offering (IPO) market has kicked off 2026 with exceptional momentum, recording its ...

Musk's xAI, SpaceX combo is the biggest merger of all time, valued at $1.25 trillion

The record-setting deal will be the largest merger of all time and is valued at $1.25 trillion ...
The Manila Times

Agomab Announces Launch of Initial Public Offering

AgomAb Therapeutics NV ('Agomab”), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on ...

Elon Musk combines his rocket and AI businesses before an expected IPO this year

Elon Musk is joining his space exploration and artificial intelligence ventures into a single company before a massive planned initial public offering for the business later this year ...